Unknown

Dataset Information

0

Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo.


ABSTRACT: Loss of function mutations in progranulin (GRN) cause frontotemporal dementia, but how GRN haploinsufficiency causes neuronal dysfunction remains unclear. We previously showed that GRN is neurotrophic in vitro. Here, we used an in vivo axonal outgrowth system and observed a delayed recovery in GRN-/- mice after facial nerve injury. This deficit was rescued by reintroduction of human GRN and relied on its C-terminus and on neuronal GRN production. Transcriptome analysis of the facial motor nucleus post injury identified cathepsin D (CTSD) as the most upregulated gene. In aged GRN-/- cortices, CTSD was also upregulated, but the relative CTSD activity was reduced and improved upon exogenous GRN addition. Moreover, GRN and its C-terminal granulin domain granulinE (GrnE) both stimulated the proteolytic activity of CTSD in vitro. Pull-down experiments confirmed a direct interaction between GRN and CTSD. This interaction was also observed with GrnE and stabilized the CTSD enzyme at different temperatures. Investigating the importance of this interaction for axonal regeneration in vivo we found that, although individually tolerated, a combined reduction of GRN and CTSD synergistically reduced axonal outgrowth. Our data links the neurotrophic effect of GRN and GrnE with a lysosomal chaperone function on CTSD to maintain its proteolytic capacity.

SUBMITTER: Beel S 

PROVIDER: S-EPMC5886064 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo.

Beel Sander S   Moisse Matthieu M   Damme Markus M   De Muynck Louis L   Robberecht Wim W   Van Den Bosch Ludo L   Saftig Paul P   Van Damme Philip P  

Human molecular genetics 20170801 15


Loss of function mutations in progranulin (GRN) cause frontotemporal dementia, but how GRN haploinsufficiency causes neuronal dysfunction remains unclear. We previously showed that GRN is neurotrophic in vitro. Here, we used an in vivo axonal outgrowth system and observed a delayed recovery in GRN-/- mice after facial nerve injury. This deficit was rescued by reintroduction of human GRN and relied on its C-terminus and on neuronal GRN production. Transcriptome analysis of the facial motor nucleu  ...[more]

Similar Datasets

| S-EPMC3508877 | biostudies-other
| S-EPMC6666309 | biostudies-literature
| S-EPMC4409142 | biostudies-literature
| S-EPMC3907036 | biostudies-literature
| S-EPMC4962095 | biostudies-literature
| S-EPMC5772162 | biostudies-literature
| S-EPMC5439702 | biostudies-literature
| S-EPMC5701428 | biostudies-literature
| S-EPMC4123686 | biostudies-literature
| S-EPMC6613950 | biostudies-literature